THU0052 USTEKINUMAB AND GUSELKUMAB TREATMENT RESULTS IN DIFFERENCES IN SERUM IL17A, IL17F AND CRP LEVELS IN PSORIATIC ARTHRITIS PATIENTS: A COMPARISON FROM USTEKINUMAB PH3 AND GUSELKUMAB PH2 PROGRAMS - Concepedia

Concepedia

Publication | Open Access

THU0052 USTEKINUMAB AND GUSELKUMAB TREATMENT RESULTS IN DIFFERENCES IN SERUM IL17A, IL17F AND CRP LEVELS IN PSORIATIC ARTHRITIS PATIENTS: A COMPARISON FROM USTEKINUMAB PH3 AND GUSELKUMAB PH2 PROGRAMS

DOI Full Paper Access

11

Citations

1

References

2019

Year

Stefan Siebert, Matthew J. Loza, Qingxuan Song, Iain B. McInnes, Kristen Sweet

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1